By Counterforce Health Team in Increlex (mecasermin) —

How to Get Increlex (Mecasermin) Covered by Humana in Michigan: Complete Timeline, Forms & Appeals Guide

Answer Box: Getting Increlex Covered by Humana in Michigan

Humana requires prior authorization for Increlex (mecasermin) with strict criteria for severe primary IGF-1 deficiency. The fastest path to approval involves submitting complete documentation through your pediatric endocrinologist, including IGF-1 levels ≤-3.0 SDS, normal growth hormone stimulation tests, and comprehensive growth charts. If denied, Michigan residents have strong appeal rights through DIFS external review within 127 days of Humana's final decision.

First step today: Have your child's endocrinologist gather all IGF-1 labs, growth hormone tests, and growth measurements, then submit the prior authorization through Humana's Clinical Pharmacy Review portal with complete medical necessity documentation.

Table of Contents

  1. What Affects Approval Timing
  2. Pre-Submission Preparation (0-2 Days)
  3. Submission to Initial Review (1-5 Days)
  4. Additional Information Requests (1-7 Days)
  5. Decision Window & Outcomes
  6. If Denied: Michigan Appeal Process
  7. Renewal Cycles & Maintenance
  8. Timeline Visual & Milestones
  9. Time-Saving Tips
  10. FAQ

What Affects Approval Timing

Several key factors determine how quickly Humana approves Increlex coverage in Michigan:

Benefit Type: Medicare Advantage Part D plans follow federal timelines of 7 days for standard decisions, while commercial plans may have different processing speeds.

Criteria Complexity: Increlex requires meeting multiple strict criteria simultaneously—severe primary IGF-1 deficiency (not secondary causes), specific lab values, growth parameters, and safety protocols. Missing any single element triggers delays or denials.

Documentation Completeness: Well-documented submissions with all required elements typically receive faster processing. Humana's PA denial rate of ~3.5% is among the lowest of major insurers, but denials often stem from incomplete documentation rather than medical necessity disputes.

Pre-Submission Preparation (0-2 Days)

Essential Documentation Checklist

Before submitting your prior authorization, gather these required documents:

Laboratory Results:

  • IGF-1 levels with age/sex-adjusted reference ranges and SDS calculations (must be ≤-3.0)
  • Growth hormone stimulation test results showing normal or elevated levels (≥7-10 ng/mL peak)
  • IGFBP-3 levels
  • Complete thyroid function tests to exclude hypothyroidism
  • Nutritional assessment labs

Growth Documentation:

  • Serial height measurements with percentiles and SDS calculations
  • Growth velocity documentation (typically <25th percentile)
  • Bone age X-ray confirming open epiphyses
  • Growth charts spanning at least 6-12 months

Clinical Records:

  • Pediatric endocrinology consultation notes
  • Diagnosis confirmation (ICD-10 code E34.3 for severe primary IGF-1 deficiency)
  • Previous treatment history and outcomes
  • Comprehensive hypoglycemia monitoring plan
Tip: Request all lab reports include age and sex-adjusted reference ranges with SDS calculations. Many denials occur because labs lack proper normalization for pediatric patients.

Submission to Initial Review (1-5 Days)

How to Submit

Electronic Submission (Fastest): Submit through CoverMyMeds portal or Humana's provider portal. Electronic submissions typically receive initial review within 24-72 hours.

Alternative Methods:

  • Fax: Use plan-specific fax numbers (verify current number through Humana provider services)
  • Phone: 866-421-5663 (Monday-Friday, 7 AM-7 PM CT)

What Reviewers Check First

Humana's clinical pharmacy team follows a systematic review process:

  1. Formulary Status: Verify Increlex is on your specific plan's formulary
  2. Age Verification: Confirm patient is 2-18 years old
  3. Primary Diagnosis: Ensure severe primary IGF-1 deficiency diagnosis is documented
  4. Lab Values: Check that IGF-1 ≤-3.0 SDS and GH stimulation is normal/elevated
  5. Growth Parameters: Verify height ≤-3.0 SDS with poor growth velocity

Additional Information Requests (1-7 Days)

If Humana requests additional information, respond quickly to avoid processing delays:

Common Requests:

  • Clarification of IGF-1 reference ranges
  • Additional growth hormone testing results
  • Detailed hypoglycemia monitoring protocols
  • Prior therapy documentation (if applicable)

How to Respond: Submit additional documentation through the same portal used for initial submission. Include the original prior authorization reference number and clearly label supplemental materials.

Hold Queue Prevention: Incomplete responses often place requests in hold queues for weeks. Ensure all requested information is provided in a single, comprehensive submission.

Decision Window & Outcomes

Standard Processing Times

  • Medicare Part D: 7 calendar days for standard decisions
  • Expedited Reviews: 72 hours with documented medical urgency
  • Commercial Plans: Varies by specific plan terms

Reading Approval Letters

Approved: Look for specific quantity limits, refill restrictions, and renewal dates. Note any conditions or monitoring requirements.

Conditional Approval: May require additional safety protocols or specialist oversight before dispensing.

Specialty Pharmacy Routing

Once approved, Increlex must be dispensed through Humana's contracted specialty pharmacies. Common networks include Accredo, CVS Specialty, or Walgreens Specialty Pharmacy.

If Denied: Michigan Appeal Process

Michigan residents have robust appeal rights through a two-step process:

Step 1: Internal Humana Appeal

Timeline: File within 65 days of denial notice for Medicare plans Submission: Use Humana's online appeals portal or mail to: Humana Grievances and Appeals
P.O. Box 14546
Lexington, KY 40512-4546

Required Elements:

  • Copy of original denial letter
  • Medical necessity letter from pediatric endocrinologist
  • All supporting clinical documentation
  • Specific rebuttal to denial reasons

Step 2: Michigan DIFS External Review

If Humana upholds the denial, Michigan's Department of Insurance and Financial Services (DIFS) provides independent review:

Timeline: File within 127 days of Humana's final denial decision Submission: Complete DIFS external review form online or via mail Cost: Free to consumers Decision: DIFS typically decides within 60 days; expedited reviews within 72 hours for urgent cases

Note: Michigan's 127-day filing deadline is longer than the federal 120-day standard, giving families additional time to prepare comprehensive appeals.

Expedited Appeals for Rare Diseases

Increlex often qualifies for expedited review due to its use in rare growth disorders:

Criteria: Pre-service denials where delay would jeopardize health Required: Physician letter documenting medical urgency Timeline: 72-hour decision from DIFS

Renewal Cycles & Maintenance

Initial Approval Period

Most Increlex approvals are granted for 6-12 months, requiring renewal with:

  • Updated growth measurements demonstrating adequate response (≥4 cm/year)
  • Continued evidence of open epiphyses
  • Ongoing safety monitoring documentation
  • Confirmation that IGF-1 deficiency persists

What Speeds Renewals

  • Documented growth response to treatment
  • Consistent specialist oversight
  • Comprehensive safety monitoring records
  • No significant adverse events

Timeline Visual & Milestones

Milestone Timeline Key Actions
Documentation Gathering 0-2 days Collect labs, growth charts, specialist notes
PA Submission Day 1 Submit via portal with complete documentation
Initial Review 1-5 days Humana clinical pharmacy review
Additional Info Request 1-7 days Respond quickly to avoid delays
Decision 7 days (standard) Approval, denial, or conditional approval
Internal Appeal 65 days to file Submit comprehensive rebuttal
DIFS External Review 127 days to file Independent medical review
Final Decision 60 days (standard) Binding determination

Time-Saving Tips

Portal Usage: Electronic submissions through CoverMyMeds or Humana's provider portal process fastest and provide real-time status tracking.

Bundled Evidence: Submit all required documentation simultaneously rather than piecemeal to avoid multiple review cycles.

Direct Specialty Routing: Once approved, coordinate directly with Humana's contracted specialty pharmacies to expedite dispensing.

Peer-to-Peer Reviews: If facing denial, request a peer-to-peer review between your pediatric endocrinologist and Humana's medical director.

For families navigating complex prior authorization requirements, Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with payer-specific requirements, potentially saving weeks in the appeals process.

FAQ

How long does Humana prior authorization take for Increlex in Michigan? Standard decisions are made within 7 calendar days for Medicare Part D plans. Expedited reviews with documented urgency are decided within 72 hours.

What if Increlex is non-formulary on my Humana plan? Request a formulary exception through Humana's Clinical Pharmacy Review, demonstrating that covered alternatives would be less effective or cause adverse effects for your child's specific condition.

Can I request an expedited appeal in Michigan? Yes, both Humana (72 hours) and Michigan DIFS (72 hours) offer expedited appeals when delays would jeopardize health, requiring a physician letter documenting urgency.

Does step therapy apply if my child failed growth hormone outside Michigan? Document all prior therapy failures with growth charts and specialist notes. Out-of-state treatment records are acceptable if properly documented.

What happens if DIFS overturns Humana's denial? The decision is binding—Humana must provide coverage as directed by the independent medical review.

How much does Increlex cost without insurance? Retail cash prices typically exceed $16,000 per 4 mL vial. Check with Increlex's manufacturer for patient assistance programs.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider and insurance plan for personalized guidance. Coverage decisions depend on individual medical circumstances and specific plan terms.

Sources & Further Reading:

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.